查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1545567

全球阵列设备市场

Array Instruments
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球阵列设备市场预计将达27亿美元

2023年全球阵列设备市场预计为19亿美元，预计到2030年将达到27亿美元，2023-2030年分析期间复合年增长率为5.3%。 DNA 微阵列技术是本报告分析的细分市场之一，预计复合年增长率为 5.4%，到分析期结束时将达到 14 亿美元。分析期间，蛋白质微阵列技术领域的复合年增长率预计为 5.8%。

美国市场预估为5.076亿美元，中国预期复合年增长率为5.1%

预计2023年美国阵列设备市场规模将达5.076亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到4.227亿美元，2023年至2030年复合年增长率为5.1%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 5.1% 和 4.1%。在欧洲，德国的复合年增长率预计为 4.4%。

全球阵列设备市场 - 主要趋势与驱动因素总结

阵列设备如何彻底改变生物医学研究？

阵列仪器在分析复杂的生物资料方面提供了前所未有的能力，并已成为生物医学研究领域的重要工具。这些仪器，包括 DNA 微阵列、蛋白质阵列和组织阵列，使研究人员能够同时研究数千个基因、蛋白质和其他生物分子的表现。阵列仪器的高通量性质彻底改变了科学家研究基因体学、蛋白质体学和个人化医疗的方式，以实现更全面、更准确的分析。阵列设备可以轻鬆地同时研究多种生物标记物，从而加快了癌症研究、遗传疾病和药物开发等领域的发现步伐。快速准确评估基因表现模式和蛋白质相互作用的能力使这些仪器成为现代实验室业务的基石，从而在了解疾病机制和潜在治疗标靶方面取得重大进展。

增强阵列设备能力的技术创新有哪些？

不断的技术创新推动了阵列设备的发展，这些创新扩大了阵列设备的功能和应用范围。微阵列技术的最新进展提高了这些仪器的灵敏度、特异性和分辨率，使它们能够检测基因和蛋白质表现的最小变化。此外，先进计算工具的整合提高了资料分析能力，使研究人员能够更准确、更有效率地解释复杂的资料集。阵列设计的创新，例如高密度阵列的开发，进一步提高了这些设备的吞吐量，使它们比以往任何时候都更强大。此外，可以同时分析多种类型生物分子的多重阵列的出现开闢了新的研究途径，特别是在系统生物学领域。这些技术进步不仅提高了阵列元件的性能，而且扩大了其应用范围，使其在从基础科学到临床诊断的广泛研究领域中不可或缺。

为什么阵列设备对于个人化医疗和诊断很重要？

阵列设备在个人化医疗和诊断的发展中发挥着至关重要的作用，其中精确度和准确性至关重要。阵列设备彻底改变了疾病的诊断和治疗方式，因为它们可以提供个别患者的详细分子特征。在个人化医疗中，阵列设备用于识别特定的基因突变和表达模式，从而预测患者对特定治疗的反应，从而实现更量身定制和有效的治疗策略。诊断能够检测指示癌症、心血管疾病和自体免疫疾病等疾病的存在或进展的生物标记。在临床实践中采用阵列设备将有助于从一刀切到个人化护理的转变，从而改善患者的治疗效果并降低医疗成本。随着对个人化医疗保健解决方案的需求持续增长，阵列设备在研究和临床环境中的重要性预计将显着增长。

阵列设备市场成长的驱动力是什么？

阵列设备市场的成长是由影响其扩张和发展的多个因素所推动的。一个关键驱动因素是生物医学研究中对高通量技术的需求不断增长，其中需要快速、准确地分析大型资料集。个人化医疗的兴起也对市场成长做出了重大贡献。医疗保健提供者正在寻求先进的分子诊断工具和量身定制的治疗策略。下一代微阵列的开发以及人工智慧和机器学习在资料分析中的整合等技术进步透过提高这些仪器的功能和效率进一步推动了市场。阵列设备在癌症研究、药物开发和农业生物技术等领域的广泛应用正在为市场成长创造新的机会。此外，人们越来越重视疾病的早期发现和精准医疗的发展，阵列设备越来越多地应用于临床诊断，特别是在医疗基础设施发达的已开发国家。随着这些趋势的不断发展，在创新以及研究和医疗保健领域对先进分析工具日益增长的需求的推动下，阵列设备市场有望实现持续成长。

受访企业范例（共43例）

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings（LabCorp）
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC.
  • MilliporeSigma
  • Mingyuan Medicare Development Company Limited
  • Molecular Devices LLC
  • Novus Biologicals LLC
  • OriGene Technologies, Inc.
  • Orla Protein Technologies Ltd.
  • Oxford Gene Technology
  • Partek, Inc.
  • Pepscan
  • PerkinElmer, Inc.
  • Phalanx Biotech Group
  • ProteoGenix
  • Qiagen NV
  • RayBiotech, Inc.
  • Retrogenix Ltd.
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10375

Global Array Instruments Market to Reach US$2.7 Billion by 2030

The global market for Array Instruments estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. DNA Microarrays Technology, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Protein Microarrays Technology segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$507.6 Million While China is Forecast to Grow at 5.1% CAGR

The Array Instruments market in the U.S. is estimated at US$507.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$422.7 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Array Instruments Market - Key Trends and Drivers Summarized

How Are Array Instruments Revolutionizing Biomedical Research?

Array instruments have become indispensable tools in the field of biomedical research, offering unprecedented capabilities in analyzing complex biological data. These instruments, which include DNA microarrays, protein arrays, and tissue arrays, enable researchers to study the expression of thousands of genes, proteins, or other biomolecules simultaneously. The high-throughput nature of array instruments has transformed the way scientists approach genomics, proteomics, and personalized medicine, allowing for more comprehensive and precise analyses. By facilitating the simultaneous examination of multiple biomarkers, array instruments have accelerated the pace of discovery in areas such as cancer research, genetic disorders, and drug development. The ability to quickly and accurately assess gene expression patterns and protein interactions has made these instruments a cornerstone of modern laboratory practices, leading to significant advancements in our understanding of disease mechanisms and potential therapeutic targets.

What Technological Innovations Are Enhancing the Capabilities of Array Instruments?

The evolution of array instruments has been driven by continuous technological innovations that have expanded their functionality and application scope. Recent advancements in microarray technology have increased the sensitivity, specificity, and resolution of these instruments, enabling the detection of even minute changes in gene or protein expression. Additionally, the integration of advanced computational tools has enhanced data analysis capabilities, allowing researchers to interpret complex datasets with greater accuracy and efficiency. Innovations in array design, such as the development of high-density arrays, have further increased the throughput of these instruments, making them more powerful than ever before. Moreover, the emergence of multiplexed arrays, which can analyze multiple types of biomolecules simultaneously, has opened new avenues for research, particularly in the field of systems biology. These technological strides have not only improved the performance of array instruments but have also broadened their applicability, making them essential in a wide range of research areas, from basic science to clinical diagnostics.

Why Are Array Instruments Critical in Personalized Medicine and Diagnostics?

Array instruments play a pivotal role in the advancement of personalized medicine and diagnostics, where precision and accuracy are paramount. The ability of these instruments to provide detailed molecular profiles of individual patients has revolutionized the way diseases are diagnosed and treated. In personalized medicine, array instruments are used to identify specific genetic mutations or expression patterns that can predict a patient’s response to certain therapies, allowing for more tailored and effective treatment strategies. In diagnostics, these instruments enable the detection of biomarkers that can indicate the presence or progression of diseases such as cancer, cardiovascular conditions, and autoimmune disorders. The adoption of array instruments in clinical settings has facilitated the transition from one-size-fits-all treatment approaches to more individualized care, improving patient outcomes and reducing healthcare costs. As the demand for personalized healthcare solutions continues to grow, the importance of array instruments in both research and clinical practice is expected to increase significantly.

What Is Driving the Growth of the Array Instruments Market?

The growth in the array instruments market is driven by several factors that are shaping its expansion and evolution. A key driver is the increasing demand for high-throughput technologies in biomedical research, where the need to analyze large datasets quickly and accurately is paramount. The rise of personalized medicine has also significantly contributed to market growth, as healthcare providers seek advanced tools for molecular diagnostics and tailored treatment strategies. Technological advancements, such as the development of next-generation microarrays and the integration of AI and machine learning in data analysis, are further propelling the market by enhancing the capabilities and efficiency of these instruments. The expanding application of array instruments in areas such as cancer research, drug development, and agricultural biotechnology is creating new opportunities for market growth. Additionally, the growing emphasis on early disease detection and the development of precision medicine are driving the adoption of array instruments in clinical diagnostics, particularly in developed countries with advanced healthcare infrastructures. As these trends continue to evolve, the array instruments market is poised for sustained growth, driven by innovation and the expanding need for sophisticated analytical tools in both research and healthcare.

Select Competitors (Total 43 Featured) -

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC.
  • MilliporeSigma
  • Mingyuan Medicare Development Company Limited
  • Molecular Devices LLC
  • Novus Biologicals LLC
  • OriGene Technologies, Inc.
  • Orla Protein Technologies Ltd.
  • Oxford Gene Technology
  • Partek, Inc.
  • Pepscan
  • PerkinElmer, Inc.
  • Phalanx Biotech Group
  • ProteoGenix
  • Qiagen NV
  • RayBiotech, Inc.
  • Retrogenix Ltd.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Array Instruments - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Technologies Spurs Growth of Array Instruments
    • Technological Advancements in Microarray Design Expands Addressable Market Opportunity
    • Increasing Application in Cancer Research Propels Growth in Array Instruments Market
    • Advancements in Multiplexed Arrays Generate Opportunities for Systems Biology Research
    • Growing Focus on Early Disease Detection Throws the Spotlight on Clinical Diagnostics
    • Expansion of Genomic Research Drives Adoption of Next-Generation Microarrays
    • Growing Need for Comprehensive Biomarker Analysis Drives Innovation in Array Technologies
    • Increased Use of Arrays in Agricultural Biotechnology Expands Application Scope
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for R&D Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Clinical Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Array Instruments Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for DNA Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Protein Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION